$ASII
Accredited Solutions, Inc. Stock $asii

$asii Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000147793221005885 Filed on August 23, 2021

Income Statement

Concept	2021 Q3	2021 Q2	2020 Q2
Revenue	$416.3K	$455.5K	$210.9K
YoY Change	308.12%	115.99%	97.22%
Cost Of Revenue	$408.8K	$419.6K	$144.6K
YoY Change	426.15%	190.16%	34.5%
Gross Profit	$7.570K	$35.99K	$66.31K
YoY Change	-68.88%	-45.73%	-11941.25%
Gross Profit Margin	1.82%	7.9%	31.44%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$420.3K	$227.5K
YoY Change
% of Gross Profit	5552.71%	632.16%
Operating Expenses	$651.0K	$15.00	$86.15K
YoY Change	123.77%	-99.98%	171.25%
Operating Profit	-$643.4K	-$15.00	-$19.84K
YoY Change	141.35%	-99.92%	-38.62%
Interest Expense	$103.3K	$50.55K	$3.366K
YoY Change	3134.87%	1401.9%
% of Operating Profit
Other Income/Expense, Net	-$1.193M	-$2.001M	-$632.8K
YoY Change	-1122.78%	216.24%	35856.42%
Pretax Income	$6.793K	$17.72K	$0.00
YoY Change			-100.0%
Income Tax
% Of Pretax Income
Net Earnings	-$1.857M	-$15.00	-$652.7K
YoY Change	1138.42%	-100.0%	1814.89%
Net Earnings / Revenue	-446.03%	0.0%	-309.47%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	-$81.33K	$0.00	-$29.73K
COMMON SHARES
Basic Shares Outstanding	23.44M shares
Diluted Shares Outstanding	102.5M shares	101.3M shares

Balance Sheet

Concept	2021 Q3	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.41K	$105.3K	$36.14K
YoY Change	-64.48%	191.42%	-76.31%
Cash & Equivalents	$13.41K	$10.16K	$36.14K
Short-Term Investments
Other Short-Term Assets	$167.2K	$181.4K	$7.860K
YoY Change	28.04%	2207.38%
Inventory	$0.00	$103.4K	$199.5K
Prepaid Expenses	$166.9K	$181.4K
Receivables	$64.80K	$70.85K	$99.98K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$245.5K	$460.9K	$343.5K
YoY Change	-29.58%	34.2%	72.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$130.1K	$137.1K
YoY Change
Goodwill	$563.5K	$563.5K
YoY Change
Intangibles	$12.00K	$12.00K
YoY Change
Long-Term Investments	$66.99K	$66.99K
YoY Change	5.61%
Other Assets
YoY Change
Total Long-Term Assets	$772.6K	$1.193M	$2.712M
YoY Change	-72.16%	-56.01%	22500.0%
TOTAL ASSETS
Total Short-Term Assets	$245.5K	$460.9K	$343.5K
Total Long-Term Assets	$772.6K	$1.193M	$2.712M
Total Assets	$1.018M	$1.654M	$3.055M
YoY Change	-67.41%	-45.87%	1344.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$84.63K	$101.5K	$91.92K
YoY Change	-41.67%	10.4%	137.52%
Accrued Expenses	$128.1K	$155.1K	$34.00K
YoY Change	287.98%	356.09%
Deferred Revenue
YoY Change
Short-Term Debt	$1.563M	$1.648M	$990.3K
YoY Change	121.27%	66.45%	260.57%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.523M	$5.627M	$3.240M
YoY Change	113.27%	73.66%	933.99%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.523M	$5.627M	$3.240M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$6.523M	$5.627M	$3.240M
YoY Change	113.27%	73.66%	933.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.11M	-$12.26M
YoY Change
Common Stock	$23.45K	$22.54K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.505M	$22.17K	-$184.7K
YoY Change
Total Liabilities & Shareholders Equity	$1.018M	$1.654M	$3.055M
YoY Change	-67.41%	-45.87%	1344.67%

Cashflow Statement

Concept	2021 Q3	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	-$1.857M	-$15.00	-$652.7K
YoY Change	1138.42%	-100.0%	1814.89%
Depreciation, Depletion And Amortization	$420.3K	$227.5K
YoY Change
Cash From Operating Activities	-$281.3K	-$113.4K	-$1.465M
YoY Change	-418.54%	-92.26%	915.71%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$47.00K
YoY Change
Acquisitions		$500.0K
YoY Change
Other Investing Activities	$0.00	-$688.5K
YoY Change
Cash From Investing Activities	$0.00	-$735.5K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	189.7K	368.3K	1.479M
YoY Change	-314.82%	-75.1%	868.6%
NET CHANGE
Cash From Operating Activities	-281.3K	-113.4K	-1.465M
Cash From Investing Activities	0.000	-735.5K
Cash From Financing Activities	189.7K	368.3K	1.479M
Net Change In Cash	-91.59K	-480.5K	14.39K
YoY Change	39337605464063990.0%	-3439.4%	69.29%
FREE CASH FLOW
Cash From Operating Activities	-$281.3K	-$113.4K	-$1.465M
Capital Expenditures	$0.00	-$47.00K
Free Cash Flow	-$281.3K	-$66.38K
YoY Change	-418.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23435967	shares
CY2021Q2	us-gaap	Cash Cash	105316	USD
CY2020Q4	us-gaap	Cash Cash	21233	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	70854	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4689	USD
CY2021Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	103408	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	163567	USD
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	181363	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9541	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	460941	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	199030	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	137149	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	USD
CY2021Q2	gdhp	Branding Agreement BrandingAgreement	413265	USD
CY2020Q4	gdhp	Branding Agreement BrandingAgreement	1735714	USD
CY2021Q2	us-gaap	Investments Investments	66988	USD
CY2020Q4	us-gaap	Investments Investments	63433	USD
CY2021Q2	us-gaap	Goodwill Goodwill	563524	USD
CY2020Q4	us-gaap	Goodwill Goodwill	0	USD
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12000	USD
CY2021Q2	us-gaap	Assets Assets	1653867	USD
CY2020Q4	us-gaap	Assets Assets	2010177	USD
	us-gaap	Operating Expenses OperatingExpenses	165587	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-446359	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	101480	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	-405315	USD
CY2021Q2	gdhp	Non Controlling Interest NonControllingInterest	-17719	USD
CY2020Q4	gdhp	Non Controlling Interest NonControllingInterest	0	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-3972896	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19203	USD
CY2021Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	159832	USD
CY2020Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	82832	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	482345	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-405315	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1653867	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	43465	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	0	USD
CY2021Q2	us-gaap	Interest Payable Current InterestPayableCurrent	12807	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	35320	USD
CY2021Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	98798	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	45057	USD
CY2021Q2	us-gaap	Notes Payable Current NotesPayableCurrent	19100	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	19100	USD
CY2021Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1118682	USD
CY2020Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	286910	USD
CY2021Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	510575	USD
CY2020Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	400575	USD
CY2021Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3562024	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1526495	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5626763	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2415492	USD
CY2021Q2	us-gaap	Liabilities Liabilities	5626763	USD
CY2020Q4	us-gaap	Liabilities Liabilities	2415492	USD
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	250000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	250000	shares
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	250	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	250	USD
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22542634	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22263829	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	22543	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	22264	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8284626	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7962062	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12262596	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8389891	USD
CY2021Q2	us-gaap	Minority Interest MinorityInterest	-3955177	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2010177	USD
CY2021Q2	us-gaap	Revenues Revenues	455537	USD
CY2020Q2	us-gaap	Revenues Revenues	210903	USD
	us-gaap	Revenues Revenues	529341	USD
	us-gaap	Revenues Revenues	281346	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	419551	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	144592	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	475005	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	212469	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	35986	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	66311	USD
	us-gaap	Gross Profit GrossProfit	54336	USD
	us-gaap	Gross Profit GrossProfit	68877	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-19838	USD
	us-gaap	Operating Expenses OperatingExpenses	1880405	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	86149	USD
CY2020Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-841222	USD
CY2021Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1826069	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-96710	USD
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	4	USD
CY2021Q2	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	0	USD
CY2020Q2	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	0	USD
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	38910	USD
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	0	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	50554	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	3366	USD
	us-gaap	Interest Expense InterestExpense	67740	USD
	us-gaap	Interest Expense InterestExpense	17168	USD
CY2021Q2	gdhp	Gain Loss On Derivative Liabilities GainLossOnDerivativeLiabilities	-1950700	USD
CY2020Q2	gdhp	Gain Loss On Derivative Liabilities GainLossOnDerivativeLiabilities	-629782	USD
	gdhp	Gain Loss On Derivative Liabilities GainLossOnDerivativeLiabilities	-2035529	USD
	gdhp	Gain Loss On Derivative Liabilities GainLossOnDerivativeLiabilities	-727344	USD
CY2021Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	USD
CY2020Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	315	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2001250	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-632833	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2064355	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-744512	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2447609	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-652671	USD
	us-gaap	Net Income Loss NetIncomeLoss	-3890424	USD
	us-gaap	Net Income Loss NetIncomeLoss	-841222	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17719	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	0	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17719	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	0	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-2429890	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-652671	USD
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-3872705	USD
CY2021Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22388663	shares
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	21952470	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22338347	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	17776646	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-405315	USD
CY2021Q1	gdhp	Issuance Of Common Stock For Financing Amount IssuanceOfCommonStockForFinancingAmount	78000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	26400	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10443	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-1442815	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-1733287	USD
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	208000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2447609	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-3972896	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-2057435	USD
CY2020Q1	gdhp	Issuance Of Common Shares Branding Agreement Amount IssuanceOfCommonSharesBrandingAgreementAmount	2700000	USD
CY2020Q1	gdhp	Shares Issued To William Alessi Amount SharesIssuedToWilliamAlessiAmount	7000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59868	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48088	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	105316	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36140	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	78000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	0	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	0	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	31671	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	5307	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-438179	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1543409	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	689055	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	47000	USD
	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-736055	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	gdhp	Spire Branding Agreement For Common Stock SpireBrandingAgreementForCommonStock	0	USD
CY2020Q1	gdhp	Shares Issued To Chris Chumas Amount SharesIssuedToChrisChumasAmount	7000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-188551	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	468014	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-652671	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-184657	USD
	us-gaap	Net Income Loss NetIncomeLoss	-3890424	USD
	us-gaap	Net Income Loss NetIncomeLoss	-841222	USD
	us-gaap	Depreciation Depreciation	7079	USD
	us-gaap	Depreciation Depreciation	0	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1322449	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	0	USD
	gdhp	Non Cash Interest Expense NonCashInterestExpense	0	USD
	gdhp	Non Cash Interest Expense NonCashInterestExpense	-17168	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	26400	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
	gdhp	Gain On Write Off Of Debt GainOnWriteOffOfDebt	-38910	USD
	gdhp	Gain On Write Off Of Debt GainOnWriteOffOfDebt	0	USD
	gdhp	Gain On Derivative Liabilities GainOnDerivativeLiabilities	2035529	USD
	gdhp	Gain On Derivative Liabilities GainOnDerivativeLiabilities	-727344	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-24278	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-99977	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-150321	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-7864	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	60159	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	71978	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-48	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	104735	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	72881	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	75000	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2780	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1531461	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1097182	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	128000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	208000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Sale Of Investment Projects ProceedsFromSaleOfInvestmentProjects	42500	USD
	us-gaap	Proceeds From Sale Of Investment Projects ProceedsFromSaleOfInvestmentProjects	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1219682	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1531461	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	45448	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-11948	USD
	gdhp	Spire Branding Agreement For Common Stock SpireBrandingAgreementForCommonStock	2700000	USD
	gdhp	Conversion Of Preferred Stock Into Common Stock ConversionOfPreferredStockIntoCommonStock	10000	USD
	gdhp	Conversion Of Preferred Stock Into Common Stock ConversionOfPreferredStockIntoCommonStock	14000	USD
	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 – NATURE OF OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Good Hemp, Inc. (the “Company” or “Good Hemp”), formerly known as Keyser Resources, Inc., and Lone Star Gold, Inc., was incorporated in the State of Nevada on November 26, 2007.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company was involved in the exploration and development of mining properties until September 30, 2013, when it discontinued operations. In 2017, the Company was put into receivership and in 2018, it emerged from receivership. On September 11, 2019, the Company's Board of Directors, pursuant to Nevada Revised Statute 92A.280, amended the Company's Articles of Incorporation to change the name of the Company from Lone Star Gold, Inc. to Good Hemp, Inc. The amendment was filed with the Nevada Secretary of State on September 12, 2019.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is now a North Carolina based company that is made up of industry veterans focused on exploiting niche markets in the hemp industry. Good Hemp® includes two lines of hemp-based beverages. Good Hemp® 2oh! is a hemp-derived, CBD-infused line of flavored waters, and Good Hemp® fizz! is a line of carbonated hemp oil infused sodas. Good Hemp® products have been sold throughout the United States since 2016 via Amazon.com, as well as local retailers.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">By establishing a comprehensive distribution system, Good Hemp® has secured listings for its products with regional and national grocery and convenience chain stores.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 21, 2020, the Company filed with the State of Nevada a Certificate of Designation designating 250,000 shares of the Company’s authorized preferred stock as Series B-1 Convertible Preferred Stock (the “Series B-1 Preferred Stock”). Each share of Series B-1 Preferred Stock is convertible into 1.667 shares of Company common stock (subject to a 4.99% beneficial ownership limitation). The Series B-1 Preferred Stock entitles the holder to piggy-back registration rights and one vote per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Also, on July 21, 2020, the Company filed with the State of Nevada a Certificate of Designation designating 750,000 shares of the Company’s authorized preferred stock as Series B-2 Convertible Preferred Stock (the “Series B-2 Preferred Stock”). Each share of Series B-2 Preferred Stock is convertible into a number of shares of Company common stock equal to $1.00 divided by (i) the lesser of $0.60 or 60% of the 14-day average closing price of the Company’s common stock at the time of conversion (the “Market Price”) if the conversion occurs within 6 months of July 21, 2020, or (ii) 60% of the Market Price if the conversion occurs at least 6 months after July 21, 2020 (subject to a 4.99% beneficial ownership limitation). The Series B-2 Preferred Stock entitles the holder to one vote per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 9, 2021, the Company formed Good Hemp Wellness, LLC, a limited liability company formed under the laws of the State of North Carolina, to sell CBD products to customers through chiropractic offices.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 1, 2021, the Company entered into an agreement to purchase Diamond Creek Group, LLC, a North Carolina limited liability company which sells the Diamond Creek brand of high alkaline water products, for a total purchase price of $643,000. On April 2, 2021, the Company closed the acquisition and paid the initial $500,000 portion of the purchase price, and on April 23, 2021, paid the $143,000 purchase price balance. See note 4 for the purchase price allocation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The outbreak of the coronavirus (COVID-19) resulted in increased travel restrictions, and shutdown of businesses, which may cause slower recovery of the economy. We may experience impact from quarantines, market downturns and changes in customer behavior related to pandemic fears and impact on our workforce if the virus continues to spread. In addition, one or more of our customers, partners, service providers or suppliers may experience financial distress, delayed or defaults on payment, file for bankruptcy protection, sharp diminishing of business, or suffer disruptions in their business due to the outbreak. The extent to which the coronavirus impacts our results will depend on future developments and reactions throughout the world, which are highly uncertain and will include emerging information concerning the severity of the coronavirus and the actions taken by governments and private businesses to attempt to contain the coronavirus. It is likely to result in a potential material adverse impact on our business, results of operations and financial condition. Wider-spread COVID-19 globally could prolong the deterioration in economic conditions and could cause decreases in or delays in advertising spending and reduce and/or negatively impact our short-term ability to grow our revenues. Any decreased collectability of accounts receivable, bankruptcy of small and medium businesses, or early termination of agreements due to deterioration in economic conditions could negatively impact our results of operations.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the recoverability of long-lived assets and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
	gdhp	Schedule Of Summary Purchases Towards Related Party ScheduleOfSummaryPurchasesTowardsRelatedParty	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Class A</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Preferred</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Consideration</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">William Alessi</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">12,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">200,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(1)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Chris Chumas</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(1)</p></td></tr></tbody></table>
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.106	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0700	pure
CY2021Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3562024	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1526495	USD
CY2020Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	40000	shares
CY2020Q3	us-gaap	Payments For Fees PaymentsForFees	20000	USD
CY2021Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	30000	shares
CY2021Q1	gdhp	Debt Conversion Shares DebtConversionShares	17405	shares
CY2021Q1	gdhp	Debt Conversion Amount DebtConversionAmount	77952	USD
	gdhp	Joint Venture Disclosuretextblock JointVentureDISCLOSURETEXTBLOCK	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 10 – JOINT VENTURE</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 24, 2020, with an effective date of July 1, 2020, the Company entered into a joint venture agreement with Paul Hervey (“Hervey”) for the purpose of cultivating hemp. Hervey is a licensed hemp cultivator in good standing under the laws of North Carolina with approximately 3,700 square feet of greenhouse cultivation space and approximately 9 acres of farmable land (the “Facility”). Under the joint venture agreement, Good Hemp will contribute up to $160,000 for the preparation of the Facility, as well as up to $174,000 as ongoing operational expenses for the joint venture, and Hervey will contribute exclusive use of the Facility, as well as purchase services and/or purchase or lease necessary equipment for the planting, cultivation and irrigation for growing hemp, and profits shall be split equally by the parties after reimbursement of expenses paid by the parties. The joint venture shall conduct business under the name “Olin Farms, LLC”. On or about August 20, 2020, the Company compensated Hervey $53,433.33 for the initial expenses of the joint venture. The payment was made as follows: (i) a check payable to Hervey in the amount of $33,433.33, and (ii) the issuance of 40,000 shares of Company common stock in lieu of a $20,000 cash payment. On or about August 21, 2020, the Company made an initial cash contribution to Olin Farms, LLC, in the amount of $10,000.00.</p>
CY2020Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	40000	shares
CY2020Q3	us-gaap	Payments For Fees PaymentsForFees	20000	USD
CY2020Q3	us-gaap	Legal Fees LegalFees	10000	USD

Files In Submission

Name	View Source	Status
0001477932-21-005885-index-headers.html	Edgar Link	pending
0001477932-21-005885-index.html	Edgar Link	pending
0001477932-21-005885.txt	Edgar Link	pending
0001477932-21-005885-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gdhp-20210630.xsd	Edgar Link	pending
gdhp-20210630_cal.xml	Edgar Link	unprocessable
gdhp-20210630_def.xml	Edgar Link	unprocessable
gdhp-20210630_lab.xml	Edgar Link	unprocessable
gdhp-20210630_pre.xml	Edgar Link	unprocessable
ghmp_10q.htm	Edgar Link	pending
ghmp_10q_htm.xml	Edgar Link	completed
ghmp_ex311.htm	Edgar Link	pending
ghmp_ex312.htm	Edgar Link	pending
ghmp_ex321.htm	Edgar Link	pending
ghmp_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ASII
Accredited Solutions, Inc. Stock $asii

2021 Q3 Form 10-Q Financial Statement

#000147793221005885 Filed on August 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASII Accredited Solutions, Inc. Stock $asii

2021 Q3 Form 10-Q Financial Statement

#000147793221005885 Filed on August 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASII
Accredited Solutions, Inc. Stock $asii